Live Breaking News & Updates on Global health officer
Stay updated with breaking news from Global health officer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ApiLabs, LLC: ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
GENEVA, Sept. 15, 2022 (GLOBE NEWSWIRE) -- ApiLabs, an R&D company developing innovative, affordable medical technologies to maximize healthcare...
Investegate |ApiLabs, LLC Announcements | ApiLabs, LLC: ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network
GlobeNewswire
September 15, 2022
GENEVA, Sept. 15, 2022 (GLOBE NEWSWIRE) -- ApiLabs, an R&D company developing innovative, affordable medical technologies to maximize healthcare access for patients in all world regions, has launched its ApiLabs Field Research Network (AFRN). AFRN gathers qualitative...
Europe launches the EU Non-communicable diseases (NCDs) initiative, while GSK and Novartis promise millions to support drug R&D for neglected tropical diseases and malaria.
New investment supports further innovation in malaria, tuberculosis, and HIV, with a new emphasis on Neglected Tropical Diseases and anti-microbial resistance
New investment supports further innovation in malaria, tuberculosis, and HIV, with a new emphasis on Neglected Tropical Diseases and anti-microbial resistance GSK Global Health R&D Hubs are progressing more than 30 potential new vaccines and medicines, targeting 13 high-burden infectious diseases GSK will also maintain donations of albendazole